30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Anika Launches TACTOSET Bone Repair Therapy -

Anika Therapeutics commenced U.S. commercial launch of TACTOSET injectable HA-enhanced therapy, developed to treat bone voids and other bone defects of the skeletal system caused by trauma or age-related degeneration. This is Anika’s first product to launch under its U.S.-based hybrid commercial model. TACTOSET also represents the company's first surgically-delivered regenerative therapy in the U.S. for bone repair procedures. It is an injectable, hyaluronic acid-enhanced, osteoconductive calcium phosphate bone substitute. The kit comprises an aqueous solution in a pre-loaded syringe and a dry powder that must be mixed intra-operatively using the supplied mixing system to form a paste prior to use. (Anika Therapeutics, 9/18/19)